MOLECULAR STUDY OF CALR GENE: MYELOPROLIFERATIVE NEOPLASMS (MPN) WITH NEGATIVE PHILADELPHIA AND JAK2/V617F

被引：0
|
作者：
Culurgioni, F. [1 ]
Musiu, C. [1 ]
Uda, S. [1 ]
Benziane, A. [1 ]
Pettinau, M. [1 ]
Usala, E. [1 ]
Cabras, M. G. [1 ]
机构：
[1] Ctr Trapianti Midollo Osseo PO A Businco Ao Brotz, Unita Operat Ematol, Cagliari, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PU039
引用
收藏
页码：167 / 168
页数：2
相关论文
共 50 条
  • [31] ACTIVATED STAT5 AS NOVEL STEM TARGET IN JAK2 V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS (MPN)
    Hadzijusufovic, E.
    Keller, A.
    Schur, F.
    Cerny-Reiterer, S.
    Hoermann, G.
    Mayerhofer, M.
    Boudot, C.
    Gouilleux, F.
    Muellauer, L.
    Moriggl, R.
    Valent, P.
    HAEMATOLOGICA, 2015, 100 : 524 - 525
  • [32] JAK2 V617F mutation in philadelphia chromosome-positive myeloproliferative disease
    Yun, Hyeong-Kee
    Shin, Myung-Geun
    Moon, Chang-Jin
    Kim, Hye-Ran
    Lee, Sun-Young
    Kim, Hyeoung-Joon
    Cho, Duck
    Shin, Jong-Hee
    Suh, Soon-Pal
    Ryang, Dong-Wook
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 112 - 112
  • [33] THROMBOTIC RISK ASSOCIATED WITH JAK2 V617F MUTATION AND INHERITED OR ACQUIRED THROMBOPHILIA IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Rossi, E.
    Betti, S.
    Za, T.
    Ciminello, A.
    Fresa, A.
    Bartolomei, F.
    Di Giovanni, A.
    Chiusolo, P.
    De Stefano, V.
    HAEMATOLOGICA, 2017, 102 : 97 - 97
  • [34] A study of JAK2 (V617F) gene mutation in patients with chronic myeloproliferative disorders
    Hamidah, N. H.
    Farisah, N. R.
    Azlinda, A. B.
    Wong, F. L.
    Das, S.
    Fadillah, S. A. W.
    Ainoon, O.
    CLINICA TERAPEUTICA, 2012, 163 (02): : 109 - 113
  • [35] Prevalence of JAK2V617F, CALR in Philadelphia Positive and Negative Myeloproliferative Neoplasm
    Abedi, Elham
    Karimi, Mehran
    Cohan, Nader
    Haghpanah, Sezaneh
    Yaghobi, Ramin
    Azarpira, Negar
    Moghadam, Mohamad
    Bayat, Elahe
    Farokhian, Farnoush
    Mohammadi, Hamid
    Lak, Elahe Razmara
    Golafshan, Habib Allah
    Ramzi, Mani
    GALEN MEDICAL JOURNAL, 2021, 10
  • [36] Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients
    Macedo, Luciana Conci
    Quintero, Fernanda de Cesare
    Pagliari-E-Silva, Sara
    Barbosa Pagnano, Katia Borgia
    Rodrigues, Camila
    de Alencar, Josiane Bazzo
    Sell, Ana Maria
    Laguila Visentainer, Jeane Eliete
    BLOOD CELLS MOLECULES AND DISEASES, 2016, 57 : 54 - 57
  • [37] JAK2 V617F mutation detection in chronic myeloproliferative neoplasms by digital PCR
    Waterhouse, M.
    Pfeifer, D.
    Follo, M.
    Bertz, H.
    Finke, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 196 - 196
  • [38] JAK-STAT PATHWAY IN MYELOPROLIFERATIVE NEOPLASMS: FROM JAK2 V617F TO CALRETICULIN MUTANTS
    Constantinescu, S. N.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 : 31 - 31
  • [39] Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms
    Kim, Hye-Ran
    Choi, Hyun-Jung
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Shin, Jong-Hee
    Suh, Soon-Pal
    Ryang, Dong-Wook
    Shin, Myung-Geun
    PLOS ONE, 2013, 8 (01):
  • [40] Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cells
    Cheng, Zhiyong
    Fu, Jianzhu
    Liu, Guimin
    Zhang, Lijun
    Xu, Qian
    Wang, Su-yun
    LEUKEMIA & LYMPHOMA, 2018, 59 (01) : 196 - 203
12345